Whatever the reason underlying those different outcomes are, these studies clearly show that BCR-activating environment factors might orchestrate the up-regulation of CCR7 in CLL as they do in normal B cells where CCR7 expression, following engagement of the BCR, is augmented through BCR-BTK signaling (88). This evidence concerns the gene BCR and B-cell chronic lymphocytic leukemia.